Research Projects & Grants

For Profit Organization

  • A Phase 3, Double-Blind, Multicenter, Randomized Study to Evaluate the Efficacy and Safety of Subcutaneous Twice Yearly Long-Acting Lenacapavir for HIV Pre-Exposure Prophylaxis in Cisgender Men, Transgender Women, Transgender Men, and Gender Nonbinary People >/= 16 Years of Age who Have Sex with Male Partners and are at Risk for HIV Infection, Role: Investigator, Gilead Sciences, Inc, (07/2024 - 07/2025) Status: Approved

Internal

  • Study on the use of COVID-19 monoclonal antibodies in solid organ transplant patients, Role: PI, LLU Dept. of Medicine, (05/2023) Status: Approved
  • Detection of alloreactive T lymphocyte clones to predict acute rejection after kidney transplantation, Role: Co-Investigator, LLU School of Medicine, (04/2023 - 03/2026) Status: Awarded
  • Characterization of risk factors, treatment, clinical outcomes, and burden of cytomegalovirus (CMV) infections in solid organ transplant (SOT) recipients, Role: PI, LLU Dept. of Medicine, (03/2023) Status: Approved
  • Loma Linda International Surveillance Network (LLISN), Role: Investigator, LLU Basic Science, (04/2021) Status: Approved

Non-Profit Organization

  • Integration of donor-derived cell-free DNA with HLA-DR+TNFR2+ regulatory T cell in the prediction of acute rejection and graft function after kidney transplantation, Role: Investigator, American Society of Transplant Surgeons, (08/2024 - 08/2025) Status: Approved